Answer
Ibrutinib (Imbruvica) should not be used during pregnancy because no data are available in pregnant women and animal studies have shown reproductive toxicity.
Sources for this answer
- IMBRUVICA 140 mg film-coated tablets (Great Britain)Janssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 25Document updated
Sources checked